Women's Health

Fertility pharmacists understand the importance of education, awareness, and support women need to discover in navigating the complexities of fertility.

In 2014, the cobas human papillomavirus test was approved by the FDA for first-line, primary screening in women aged 25 years and older.

A review of the literature shows the sublingual vaccine holds promise for the treatment of this condition.

Both MetS and obesity status have independent and differential associations with breast cancer, and may serve as separate targets for breast cancer prediction and prevention strategies.

The authors note that this finding may have promise for use in assessing mental health conditions and improving patient outcomes.

Knowing systemic deficits and national goals boosts awareness

Study investigators also found that dietary modifications were not associated in improving risks of certain chronic diseases and cancers.

A new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.

Compared with women who aren’t experiencing menopausal symptoms, women in the perimenopause stage were approximately 40% more likely to experience depressive symptoms.

Venture capital investments in women's health are growing, with innovation looking beyond traditional avenues.

Tisotumab vedotin-tftv is the first antibody-drug conjugate to demonstrate positive overall survival data in patients with previously treated recurrent or metastatic cancer.

Pivmecillinam (Pivya; UTILITY therapeutics Ltd) tablets were approved for female adults with uncomplicated urinary tract infection caused by Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus.

Access to birth control is a crucial part of preventive health care, but financial barriers persist

Opill is a nonprescription, progestin-only contraceptive pill, with nearly 50 years of use and data supporting the safety and effectiveness of progestin-only pills.

In the RUBY phase 3 trial, dostarlimab (Jemperli; GSK) with niraparib (Zejula; GSK) had significant progression free survival compared to the standard of care.

Fortification with folic acid may be especially beneficial in countries that do not have mandated folic acid fortification regulations.

The treatment is indicated for patients with FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers.

Oteseconazole (Vivjoa; Mycovia Pharmaceutical Inc) is the first and only medication for this indication in postmenopausal women and those who do not have reproductive potential.

The early phase clinical trial, which ended prematurely in 2013 due to funding challenges, further illustrates disparities in health equity in clinical research.

The designation is for all patients with low-grade serous ovarian cancer, regardless of their KRAS status and after 1 or more prior lines of therapy.

There have been ongoing concerns about the long-term effects of prenatal exposure on neurodevelopment.

Omega-3s are important during pregnancy because they can reduce risk of preeclampsia and other negative health outcomes.

Investigators at Duke University and the University of North Carolina determine what causes recurrent UTIs, even after antibiotics cleared the bacterial infection.

Walgreens will start dispensing the abortion pill as soon as a week.

Dietary interventions can reduce the risk of preeclampsia and other hypertensive conditions that occur during pregnancy.

In LePage v. Center for Reproductive Medicine, the Alabama Supreme Court ruled that “extrauterine embryos” are considered children, causing some infertility clinics to halt IVF processes.

In a study, nipocalimab helped more than 50% of patients with high-risk of hemolytic disease of the fetus and newborn achieve a safe live birth.

Providing continuity of care with the involvement of midwives also appeared to reduce inequities in care for multi-ethnic patients.